Mostra el registre parcial de l'element
dc.contributor.author | Miranda Alonso, Francisco Javier | |
dc.contributor.author | Alabadí Ferrer, José Antonio | |
dc.contributor.author | Lloréns, Silvia | |
dc.contributor.author | Ruiz de Apodaca, Rosa F. | |
dc.contributor.author | Centeno Guil, José M. | |
dc.contributor.author | Alborch Domínguez, Enrique | |
dc.date.accessioned | 2013-12-09T14:19:38Z | |
dc.date.available | 2013-12-09T14:19:38Z | |
dc.date.issued | 2000 | |
dc.identifier.citation | Miranda Alonso, Francisco Javier Alabadí Ferrer, José Antonio Lloréns, Silvia Ruiz de Apodaca, Rosa F Centeno Guil, José M Alborch Dominguez, Enrique 2000 Diabetes-induced changes in endothelial mechanisms implicated in rabbit carotid arterial response to 5-hydroxytryptamine. European Journal of Pharmacology 401 397 402 | |
dc.identifier.uri | http://hdl.handle.net/10550/32085 | |
dc.description.abstract | The influence of diabetes on endothelial mechanisms implicated in the response of isolated rabbit carotid arteries to 5-hydroxytryptamine (5-HT)was studied. 5-HT induced a concentration<br>dependent contraction that was potentiated in arteries from diabetic rabbits with respect to that in arteries from control rabbits. Endothelium removal potentiated 5-HT contractions in arteries from both control and diabetic rabbits but increased the maximum effect only in arteries from diabetic rabbits. Incubation of arterial segments with Nº-nitro-L-arginine(L-NA)enhanced the contractile response to 5-HT. This L-NA enhancement was greater in arteries from diabetic rabbits than in arteries from control rabbits. Aminoguanidine did not modify the 5-HT contraction in arteries from control and diabetic rabbits. Indomethacin inhibited the 5-HT-induced response, and this inhibition was higher in arteries from control rabbits than in arteries from diabetic rabbits. In summary, diabetes enhances the sensitivity of the rabbit carotid artery to 5-HT. In control animals, the endothelium modulated the arterial response to 5-HT by the release of both nitric oxide (NO) and a vasoconstrictor prostanoid. Diabetes enhances endothelial constitutive NO activity and impairs the production of the endothelial vasoconstrictor | |
dc.relation.ispartof | European Journal of Pharmacology, 2000, vol. 401, p. 397-402 | |
dc.subject | Diabetis | |
dc.subject | Òxid nítric | |
dc.subject | Endoteli vascular | |
dc.subject | Artèries | |
dc.title | Diabetes-induced changes in endothelial mechanisms implicated in rabbit carotid arterial response to 5-hydroxytryptamine | |
dc.type | journal article | es_ES |
dc.date.updated | 2013-12-09T14:19:38Z | |
dc.identifier.idgrec | 021577 | |
dc.rights.accessRights | open access | es_ES |